Skip to content

DLB DOLBY LABORATORIES INC

Follow

Stock (common), issuer CIK 1308547

Filings received so far for Q3 2026: 11 13F filers report a position in DLB shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
CX Institutional13,074$768K0.02%+34713F-HRTimeline
GAMMA Investing LLC1,452$85.3K<0.01%-23713F-HRTimeline
Farther Finance Advisors, LLC674$39.6K<0.01%-36513F-HRTimeline
Grove Bank & Trust475$27.9K<0.01%+7513F-HRTimeline
Polaris Financial Partners248$18K0.01%13F-HRTimeline
Versant Capital Management, Inc217$12.8K<0.01%+16413F-HRTimeline
EASTERN BANK142$8.35K<0.01%013F-HRTimeline
MassMutual Private Wealth & Trust, FSB101$5.94K<0.01%+3613F-HRTimeline
ELEVATION WEALTH PARTNERS, LLC72$4.23K<0.01%new13F-HRTimeline
CoreCap Advisors, LLC49$2.88K<0.01%013F-HRTimeline
GK Wealth Management LLC6$376<0.01%new13F-HRTimeline